Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction.
Goldman, L
Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. [electronic resource] - The New England journal of medicine Jul 1988 - 152-7 p. digital
Publication Type: Journal Article
0028-4793
10.1056/NEJM198807213190306 doi
Adrenergic beta-Agonists--therapeutic use
Age Factors
Aged
Cost-Benefit Analysis
Costs and Cost Analysis
Humans
Life Expectancy
Male
Middle Aged
Myocardial Infarction--drug therapy
Prognosis
Propranolol--therapeutic use
Risk Factors
Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. [electronic resource] - The New England journal of medicine Jul 1988 - 152-7 p. digital
Publication Type: Journal Article
0028-4793
10.1056/NEJM198807213190306 doi
Adrenergic beta-Agonists--therapeutic use
Age Factors
Aged
Cost-Benefit Analysis
Costs and Cost Analysis
Humans
Life Expectancy
Male
Middle Aged
Myocardial Infarction--drug therapy
Prognosis
Propranolol--therapeutic use
Risk Factors